|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine, Columbia University, NY, New York, United States
2 Medicine, Columbia University, New Yokr, New York, United States
3 New York, New York, United States; Medicine, Columbia University, New Yokr, New York, United States
4 New York, New York, United States; Medicine, Columbia University, NY, New York, United States
5 Division of Digestive and Liver Diseases, Columbia University College of Physicians and Surgeons, New York, New York, United States
* To whom correspondence should be addressed. E-mail: tcw21{at}columbia.edu.
Background: Trefoil family factor 2 (TFF2) is expressed in gastrointestinal epithelial cells where it serves to maintain mucosal integrity and promote epithelial repair. The peptide hormone, gastrin, stimulates acid secretion but also induces proliferation of the acid secreting mucosa. Since the relationship between these peptides of overlapping function is not understood, we chose to investigate the regulatory effect of gastrin on TFF2 expression. Methods: The expression of mRNA and protein of TFF2 was determined by RT-PCR and immunohistochemical staining, respectively. A series of truncated and mutant murine TFF2 promoter constructs was generated. Promoter activity was assessed using dual luciferase reporter assays. Gastrin-responsive DNA binding sites in the TFF2 promoter were evaluated by electrophoretic mobility shift assay (EMSA). Results: Gastrin significantly increased the level of endogenous mRNA of TFF2 in the gastrin receptor-expressing AGS-E gastric cancer cell line in a time- and dose- dependent manner. TFF2 protein expression in the gastric fundus was elevated in hypergastrinemic (INS-GAS) transgenic mice, and reduced in gastrin deficient mice. Gastrin treatment increased TFF2 promoter activity through cis-acting regions, containing CCAATA- and GC-rich enhancers. Pretreatment with YF476, a gastrin/CCKB receptor antagonist, abolished gastrin-dependent promoter activity. Inhibitors of PKC, MEK1 and PI3 kinase reduced gastrin-dependent TFF2 promoter activity, whereas an EGFR inhibitor had no effect. Conclusion: Gastrin regulates TFF2 transcription through a GC-rich DNA binding site and a PKC-, MEk1- and PI3 kinase-dependent but EGFR -independent pathway. Regulation of TFF2 by gastrin may play a role in the maintenance and repair of the gastrointestinal mucosa.
This article has been cited by other articles:
![]() |
S. P. Tu, A. L. Chi, W. Ai, S. Takaishi, Z. Dubeykovskaya, M. Quante, J. G. Fox, and T. C. Wang p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells Am J Physiol Gastrointest Liver Physiol, August 1, 2009; 297(2): G385 - G396. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takaishi, S. Tu, Z. A. Dubeykovskaya, M. T. Whary, S. Muthupalani, B. H. Rickman, A. B. Rogers, N. Lertkowit, A. Varro, J. G. Fox, et al. Gastrin Is an Essential Cofactor for Helicobacter-Associated Gastric Corpus Carcinogenesis in C57BL/6 Mice Am. J. Pathol., July 1, 2009; 175(1): 365 - 375. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |